Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 2 Completed
170 enrolled 19 charts
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
Completed
292 enrolled
Sleep State in Lung Cancer: A Retrospective Analysis
Completed
300 enrolled
CAR T Cells in Mesothelin Expressing Cancers
Phase 1 Completed
65 enrolled 14 charts
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
Phase NA Completed
63 enrolled
Lung Cancer Mutation Consortium Protocol
Completed
1,100 enrolled
Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
50 enrolled
CORIN
Phase 2 Completed
128 enrolled 9 charts
Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)
Completed
827 enrolled
AUTOMAN
Phase 1/2 Completed
25 enrolled
Cios Mobile 3D Spin for Robotic Bronchoscopy
Completed
38 enrolled
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
Phase 1/2 Completed
24 enrolled 8 charts
Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma
Phase 2 Completed
24 enrolled
NintNivo
Phase 1/2 Completed
56 enrolled
BLISS
Phase 2 Completed
154 enrolled
Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer
Phase 1 Completed
17 enrolled
HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008)
Completed
620 enrolled
Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011)
Completed
103 enrolled
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)
Phase 2 Completed
80 enrolled
Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma
Phase 2 Completed
27 enrolled
Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Phase 1 Completed
30 enrolled
Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma
Phase 2 Completed
47 enrolled
Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants
Completed
1,000 enrolled
Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Phase 2 Completed
13 enrolled 9 charts
US NAB With ROSE Versus US FNAB With no ROSE
Phase NA Completed
136 enrolled
Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
69 enrolled
Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy
Completed
59 enrolled
Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
Phase 2 Completed
171 enrolled 13 charts
Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy
Phase 2 Completed
37 enrolled 10 charts
Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
Phase 3 Completed
1 enrolled
Radiomics-based Prediction Model of Tumor Spread Through Air Space in Lung Adenocarcinoma
Completed
150 enrolled
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
Completed
1,060 enrolled
Whole-Exome Sequencing (WES) of Cancer Patients
Completed
244 enrolled
Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
Completed
58 enrolled
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 1 Completed
17 enrolled 12 charts
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
Phase 1 Completed
11 enrolled
An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
Completed
15 enrolled
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer
Phase 2 Completed
79 enrolled 13 charts
Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status
Phase 1 Completed
60 enrolled
Distribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital Center
Completed
114 enrolled
Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection
Phase 2 Completed
50 enrolled
Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 2 Completed
58 enrolled
EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression
Phase 2 Completed
99 enrolled
Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Phase 1/2 Completed
38 enrolled 12 charts
Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Phase 2 Completed
51 enrolled 12 charts
Low-dose Protocol for Computed Tomography-guided Lung Biopsy
Phase NA Completed
280 enrolled
Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer
Phase 2 Completed
40 enrolled
Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC
Phase 2 Completed
104 enrolled
Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).
Phase 2 Completed
149 enrolled
Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase NA Completed
13 enrolled 7 charts